Skip to main content
HISAMITSU PHARMACEUTICAL CO.,INC. logo

HISAMITSU PHARMACEUTICAL CO.,INC. — Investor Relations & Filings

Ticker · 4530 ISIN · JP3784600003 LEI · 5299006QL3IBQ4CN7E12 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2023-05-26 Regulatory Filings
Country JP Japan
Listing T 4530

About HISAMITSU PHARMACEUTICAL CO.,INC.

https://global.hisamitsu/

Hisamitsu Pharmaceutical Co., Inc. is a pharmaceutical company that develops, manufactures, and markets a range of prescription and over-the-counter (OTC) products. The company specializes in external pain relief medications, utilizing advanced transdermal drug delivery system (TDDS) technology. Its core product portfolio includes topical analgesics and anti-inflammatory formulations, such as plasters, patches, and poultices. A key brand in its OTC segment is Salonpas, a globally recognized line of pain-relieving patches. The company serves both consumer healthcare and prescription markets worldwide, focusing on providing solutions for musculoskeletal pain and inflammation.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal attestation by the CEO regarding the accuracy of the company's Annual Securities Report (Yuho). Since it is a regulatory filing required by law that does not fit into the specific categories of financial reports, presentations, or announcements, it falls under the 'Regulatory Filings' (RNS) category.
2023-05-26 Japanese
内部統制報告書－第121期(2022/03/01－2023/02/28)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This is a specific regulatory requirement in Japan regarding the assessment of internal controls over financial reporting. Since it is a standalone regulatory filing concerning internal control audit/assessment and does not fit into the other specific categories like 10-K or AR (which are broader), it is classified as a Regulatory Filing (RNS).
2023-05-26 Japanese
有価証券報告書－第121期(2022/03/01－2023/02/28)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for the 121st fiscal year (2022-03-01 to 2023-02-28) for Hisamitsu Pharmaceutical Co., Inc., filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. The presence of comprehensive financial data and the formal filing structure confirms it is an Annual Report. FY 2023
2023-05-26 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It is an officer certification by the CEO of Hisamitsu Pharmaceutical Co., Inc. confirming the accuracy of the contents of the Quarterly Report for the third quarter of the 121st fiscal period. Per the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). Q3 121
2023-01-13 Japanese
四半期報告書－第121期第3四半期(2022/09/01－2022/11/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis, and auditor review information for the third quarter of the 121st fiscal period (ending November 30, 2022). This fits the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-01-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-8, Paragraph 1. This is a standard Japanese regulatory filing that accompanies a quarterly report to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law and does not fit into the other categories like 'Interim Report' (which would be the actual financial report) or 'Report Publication Announcement', it is best classified as a Regulatory Filing (RNS).
2022-10-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.